Gail Boudreaux - 01 Mar 2024 Form 4 Insider Report for Elevance Health, Inc. (ELV)

Role: President and CEO, Director
Signature: /s/ Kathleen S. Kiefer, Attorney in fact
Issuer symbol: ELV
Transactions as of: 01 Mar 2024
Net transactions value: -$9,610,862
Form type: 4
Filing time: 05 Mar 2024, 16:21:08 UTC
Previous filing: 10 Mar 2023
Next filing: 15 Mar 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ELV	Common Stock	Tax liability	$9,610,862	-19,256	-14%	$499.11	117,777	01 Mar 2024	Direct	F1
transaction	ELV	Common Stock	Award	$0	+8,415	+7.1%	$0.000000	126,192	01 Mar 2024	Direct	F2
transaction	ELV	Common Stock	Award	$0	+34,517	+27%	$0.000000	160,709	01 Mar 2024	Direct	F3, F4
holding	ELV	Common Stock						60	01 Mar 2024	Shares Held in Spouse's Revocable Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ELV	Employee Stock Option (Right to Buy)	Award	$0	+32,480		$0.000000	32,480	01 Mar 2024	Common Stock	32,480	$499.11	Direct	F5

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.
F2	Represents restricted share units. Restrictions lapse as follows: 2,805 shares each on 3/1/2025, 3/1/2026, and 3/1/2027.
F3	Represents performance based restricted share units. Restrictions lapse on 3/1/2024.
F4	Balance includes 392.27 shares acquired on 3/24/2023, 389.71 shares acquired on 6/23/2023 and 388.21 shares acquired on 9/23/2023 through a dividend reinvestment plan.
F5	The option represents a right to purchase a total of 32,480 shares, and is exercisable in one installment of 10,826 shares and two installments of 10,827 shares each, beginning on 3/1/2025, which is the one-year anniversary of the option grant date.